Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 110, Issue 1, Pages 109-116Publisher
WILEY
DOI: 10.1111/ejh.13880
Keywords
attitudes; distress; genetic counseling; genetic testing; hematologic malignancy; leukemia
Categories
Ask authors/readers for more resources
This study surveyed 1093 leukemia patients to assess their attitudes towards genetic testing and leukemia-related distress. The findings indicate that the majority of leukemia patients have a high interest in genetic testing, experience few barriers, and have relatively low levels of distress.
Since 2003, more than 15 genes have been identified to predispose to hereditary hematologic malignancy (HHM). Although the yield of germline analysis for leukemia appears like that of solid tumors, genetic referrals in adults with leukemia remain underperformed. We assessed leukemia patients' attitudes toward genetic testing and leukemia-related distress through a survey of 1093 patients diagnosed with acute or chronic leukemia, myelodysplastic syndrome, or aplastic anemia. Principal component analysis (PCA) was used to analyze patient attitudes. Distress was measured through the Impact of Event Scale-Revised (IES-R). Exactly 19.8% of eligible respondents completed the survey. The majority reported interest in (77%) or choosing to have (78%) genetic testing for HHM. Slightly over half identified worry about cost of genetic testing (58%) or health insurance coverage (61%) as possible barriers. PCA identified relevant themes of interest in genetic testing, impact on leukemia treatment, discrimination and confidentiality, psychosocial and familial impacts, and cost of testing. The majority reported low distress. Leukemia patients report high interest in genetic testing, few barriers, and relatively low distress.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available